This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: The University of Texas System. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Diana Urbauer: Innovator in Cancer Therapy Prediction
Introduction
Diana Urbauer is a notable inventor based in Houston, Texas, recognized for her contributions to cancer therapy prediction. She has developed innovative methods that enhance the understanding of patient responses to BCG therapy for bladder cancer. Her work is pivotal in the field of oncology, particularly in predicting cancer recurrence.
Latest Patents
Diana Urbauer holds a patent titled "Use of a panel of urinary cytokines to predict response to BCG therapy for bladder cancer." This patent outlines methods for predicting cancer recurrence following BCG immunotherapy. The approach involves measuring cytokine levels from patients before and after BCG therapy, using the changes in these levels to assess the risk of cancer lapse. Additionally, her methods provide a framework for selecting patients for further anti-cancer therapies.
Career Highlights
Diana is affiliated with the University of Texas System, where she continues to advance her research and innovations. Her work has significant implications for improving patient outcomes in bladder cancer treatment. With a focus on integrating cytokine measurements into clinical practice, she is at the forefront of cancer research.
Collaborations
Diana collaborates with esteemed colleagues such as Ashish M Kamat and Joseph Briggman. Their combined expertise contributes to the development of effective cancer therapies and enhances the research environment at the University of Texas System.
Conclusion
Diana Urbauer's innovative work in predicting responses to cancer therapy exemplifies the critical role of research in improving patient care. Her contributions to the field of oncology are invaluable and continue to inspire advancements in cancer treatment methodologies.